Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.24%
SPX
+0.38%
IXIC
+0.24%
FTSE
-0.27%
N225
-0.89%
AXJO
-0.21%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...
Join our newsletter to keep up to date with us!

Key Stats

Market Cap
510.88M
Dividend Yield
0.00%
P/E Ratio
-3.24
EPS
-4.60
Revenue
83.33M
Avg. Volume
683.51K

Recently from Cashu

publisher logo
Cashu

Regenxbio: Navigating Mixed Analyst Sentiment in Gene Therapy Innovations

1 day ago
publisher logo
Cashu

RegenXBio's RGX-202 Shows Promise in Duchenne Muscular Dystrophy Gene Therapy Trial

5 days ago
publisher logo
Cashu

RegenXBio's RGX-202 Shows Promise in Duchenne Muscular Dystrophy Gene Therapy Trials

7 days ago

About

What does RGNX do?
REGENXBIO, a clinical-stage biotechnology company based in Rockville, Maryland, specializes in gene therapy using its NAV Technology Platform for retinal, neuromuscular, and neurodegenerative diseases. Its key therapies include ABBV-RGX-314, RGX-202, and RGX-121.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
Maryland, USA
Website
http://www.regenxbio.com
Stocks
Health Care
rgnx
Regenxbio
RGNX
+0.02 (+0.15%)
10.215
USD
At close at Jun 12, 20:41 UTC
Summary
News
Signals
Benchmarks
Financials